NVCR — Novocure Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Novocure, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	843	938	969	911	960
Net Total Accounts Receivable
Net Total Receivables	101	111	106	71.9	98.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	999	1,074	1,112	1,034	1,107
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41.6	53.9	69	97.7	120
Other Long Term Assets
Total Assets	1,052	1,139	1,192	1,146	1,241
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	114	143	159	179	756
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	575	729	750	784	881
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	477	410	441	362	360
Total Liabilities & Shareholders' Equity	1,052	1,139	1,192	1,146	1,241
Total Common Shares Outstanding